{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:56:08Z","timestamp":1793465768009,"version":"4.5.0"},"reference-count":149,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Achondroplasia, the most common form of short-limbed dwarfism in humans, occurs between 1 in 15,000 and 40,000 live births. More than 90% of cases are sporadic and there is, on average, an increased paternal age at the time of conception of affected individuals. More then 97% of persons with achondroplasia have a Gly380Arg mutation in the transmembrane domain of the fibroblast growth factor receptor (FGFR) 3 gene. Mutations in the FGFR3 gene also result in hypochondroplasia, the lethal thanatophoric dysplasias, the recently described SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) dysplasia, and two craniosynostosis disorders: Muenke coronal craniosynostosis and Crouzon syndrome with acanthosis nigricans. Recent evidence suggests that the phenotypic differences may be due to specific alleles with varying degrees of ligand-independent activation, allowing the receptor to be constitutively active.<\/jats:p><jats:p>Since the Gly380Arg achondroplasia mutation was recognized, similar observations regarding the conserved nature of FGFR mutations and resulting phenotype have been made regarding other skeletal phenotypes, including hypochondroplasia, thanatophoric dysplasia, and Muenke coronal craniosynostosis. These specific genotype-phenotype correlations in the FGFR disorders seem to be unprecedented in the study of human disease. The explanation for this high degree of mutability at specific bases remains an intriguing question.<\/jats:p>","DOI":"10.1210\/edrv.21.1.0387","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T18:26:51Z","timestamp":1389205611000},"page":"23-39","source":"Crossref","is-referenced-by-count":34,"title":["The Molecular and Genetic Basis of Fibroblast Growth Factor Receptor 3 Disorders: The Achondroplasia Family of Skeletal Dysplasias, Muenke Craniosynostosis, and Crouzon Syndrome with Acanthosis Nigricans*"],"prefix":"10.1210","volume":"21","author":[{"given":"Zoltan","family":"Vajo","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Medicine (Z.V.), Veterans Affairs Medical Center, Phoenix, Arizona 85012"},{"name":"Medical Genetics Branch (Z.V., C.A.F.), National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clair A.","family":"Francomano","sequence":"first","affiliation":[{"name":"Medical Genetics Branch (Z.V., C.A.F.), National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Wilkin","sequence":"first","affiliation":[{"name":"National Human Genome Research Institute and Craniofacial and Skeletal Diseases Branch (D.J.W.), National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"2020071612221685300_R1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"key":"2020071612221685300_R2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast receptor growth factor receptor-3 in achondroplasia.","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"2020071612221685300_R3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000157098","article-title":"Bone dysplasia families.","volume":"7","author":"Spranger","year":"1988","journal-title":"Pathol Immunpathol Res"},{"key":"2020071612221685300_R4","author":"Francomano","year":"1996"},{"key":"2020071612221685300_R5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat Genet"},{"key":"2020071612221685300_R6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng0795-357","article-title":"A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.","volume":"10","author":"Bellus","year":"1995","journal-title":"Nat Genet"},{"key":"2020071612221685300_R7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ng0595-11","article-title":"Stop codon FGFR3 mutations in thanatophoric dysplasia type I.","volume":"10","author":"Rousseau","year":"1995","journal-title":"Nat Genet"},{"key":"2020071612221685300_R8","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/hmg\/4.11.2097","article-title":"A common FGFR3 gene mutation in hypochondroplasia.","volume":"4","author":"Prinos","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2020071612221685300_R9","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/hmg\/4.11.2175","article-title":"Another mutation that results in the substitution of an unpaired cystine residue in the extracellular domain of FGFR-3 in thanatophoric dysplasia type I.","volume":"4","author":"Tavormina","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2020071612221685300_R10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/(SICI)1096-8628(19960503)63:1<148::AID-AJMG26>3.0.CO;2-N","article-title":"Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia and thanatophoric dwarfism.","volume":"63","author":"Bonaventure","year":"1996","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/hmg\/5.4.509","article-title":"Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I.","volume":"5","author":"Rousseau","year":"1996","journal-title":"Hum Mol Genet"},{"key":"2020071612221685300_R12","first-page":"64","article-title":"Mutations in extracellular domain of FGFR-3 produce unpaired cysteine residues in thanatophoric dysplasia type I.","volume":"4","author":"Rousseau","year":"1996","journal-title":"Eur J Hum Genet"},{"key":"2020071612221685300_R13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/hmg\/3.5.787","article-title":"Localization of the achondroplasia gene to the distal 2.5 Mb of human chromosome 4p.","volume":"3","author":"Francomano","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2020071612221685300_R14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ng0394-318","article-title":"A gene for achondroplasia-hypochondroplasia maps to chromosome 4p.","volume":"6","author":"Le Merrer","year":"1994","journal-title":"Nat Genet"},{"key":"2020071612221685300_R15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ng1096-174","article-title":"Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes.","volume":"14","author":"Bellus","year":"1996","journal-title":"Nat Genet"},{"key":"2020071612221685300_R16","author":"Johns Hopkins University","year":"1998"},{"key":"2020071612221685300_R17","first-page":"555","article-title":"A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.","volume":"60","author":"Muenke","year":"1997","journal-title":"Am J Hum Genet"},{"key":"2020071612221685300_R18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng1295-462","article-title":"Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.","volume":"11","author":"Meyers","year":"1995","journal-title":"Nat Genet"},{"key":"2020071612221685300_R19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1194-275","article-title":"Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2.","volume":"8","author":"Jabs","year":"1994","journal-title":"Nat Genet"},{"key":"2020071612221685300_R20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng1194-269","article-title":"A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome.","volume":"8","author":"Muenke","year":"1994","journal-title":"Nat Genet"},{"key":"2020071612221685300_R21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJM199501053320113","article-title":"The genetic basis of dwarfism.","volume":"332","author":"Francomano","year":"1995","journal-title":"N Engl J Med"},{"key":"2020071612221685300_R22","first-page":"153","article-title":"Mutations of FGFR3 gene cause 3 types of nanism with variable severity: achondroplasia, thanatophoric nanism and hypochodroplasia.","volume":"57","author":"Rousseau","year":"1996","journal-title":"Ann Endocrinol (Paris)"},{"key":"2020071612221685300_R23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ng0994-98","article-title":"Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome.","volume":"8","author":"Reardon","year":"1994","journal-title":"Nat Genet"},{"key":"2020071612221685300_R24","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/hmg\/4.8.1387","article-title":"Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome.","volume":"4","author":"Gorry","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2020071612221685300_R25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ng0295-108","article-title":"FGFR2 mutations in Pfeiffer syndrome.","volume":"9","author":"Lajeunie","year":"1995","journal-title":"Nat Genet"},{"key":"2020071612221685300_R26","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/hmg\/4.7.1229","article-title":"Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability.","volume":"4","author":"Park","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2020071612221685300_R27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ng0295-173","article-title":"Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes.","volume":"9","author":"Rutland","year":"1995","journal-title":"Nat Genet"},{"key":"2020071612221685300_R28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00214198","article-title":"Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome.","volume":"96","author":"Steinberger","year":"1995","journal-title":"Hum Genet"},{"key":"2020071612221685300_R29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng0295-165","article-title":"Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.","volume":"9","author":"Wilkie","year":"1995","journal-title":"Nat Genet"},{"key":"2020071612221685300_R30","first-page":"491","article-title":"FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing.","volume":"58","author":"Meyers","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2020071612221685300_R31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ng0896-492","article-title":"Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome.","volume":"13","author":"Przylepa","year":"1996","journal-title":"Nat Genet"},{"key":"2020071612221685300_R32","first-page":"923","article-title":"Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome.","volume":"58","author":"Slaney","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2020071612221685300_R33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<386::AID-HUMU18>3.0.CO;2-Z","article-title":"Crouzon syndrome: previously unrecognized deletion, duplication, and point mutation within FGFR2 gene.","volume":"8","author":"Steinberger","year":"1996","journal-title":"Hum Mutat"},{"key":"2020071612221685300_R34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/(SICI)1096-8628(19961202)66:1<81::AID-AJMG19>3.0.CO;2-M","article-title":"FGFR2 mutation in clinically nonclassifiable autosomal dominant craniosynostosis with pronounced phenotypic variation.","volume":"66","author":"Steinberger","year":"1996","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jmg.34.5.420","article-title":"A novel mutation (A886G) in exon 5 of FGFR2 in members of a family with Crouzon phenotype and plagiocephaly.","volume":"34","author":"Steinberger","year":"1997","journal-title":"J Med Genet"},{"key":"2020071612221685300_R36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s004390050584","article-title":"Jackson-Weiss syndrome: identification of two novel FGFR2 missense mutations shared with Crouzon and Pfeiffer craniosynostotic disorders.","volume":"101","author":"Tartaglia","year":"1997","journal-title":"Hum Genet"},{"key":"2020071612221685300_R37","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s004390050413","article-title":"Trp290Cys mutation in exon IIIa of the fibroblast growth factor receptor 2 (FGFR2) gene is associated with Pfeiffer syndrome.","volume":"99","author":"Tartaglia","year":"1997","journal-title":"Hum Genet"},{"key":"2020071612221685300_R38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/(SICI)1096-8628(19980724)78:4<356::AID-AJMG10>3.0.CO;2-H","article-title":"Phenotype of the fibroblast growth factor receptor 2 ser351cys mutation: Pfeiffer syndrome type III.","volume":"78","author":"Gripp","year":"1998","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/(SICI)1096-8628(19980123)75:3<252::AID-AJMG4>3.0.CO;2-S","article-title":"Novel mutation in the FGFR2 gene at the same codon as the Crouzon syndrome mutations in a severe Pfeiffer syndrome type 2 case.","volume":"75","author":"Schaefer","year":"1998","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s004390050668","article-title":"The mutations in FGFR2-associated craniosynostoses are clustered in five structural elements of immunoglobulin-like domain III of the receptor.","volume":"102","author":"Steinberger","year":"1998","journal-title":"Hum Genet"},{"key":"2020071612221685300_R41","first-page":"1","article-title":"Structural and functional diversity in the FGF receptor multigene family.","volume":"60","author":"Johnson","year":"1993","journal-title":"Adv Cancer Res"},{"key":"2020071612221685300_R42","first-page":"26","article-title":"Biological roles of fibroblast growth factor-2.","volume":"18","author":"Bikfalvi","year":"1997","journal-title":"Endocr Rev"},{"key":"2020071612221685300_R43","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1096\/fasebj.6.15.1464370","article-title":"Complexity of FGF receptors: genetic basis for structural diversity.","volume":"6","author":"Givol","year":"1992","journal-title":"FASEB J"},{"key":"2020071612221685300_R44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0065-230X(08)60305-X","article-title":"The FGF family of growth factors and oncogenes.","volume":"59","author":"Basilico","year":"1992","journal-title":"Adv Cancer Res"},{"key":"2020071612221685300_R45","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1128\/MCB.18.10.6063","article-title":"FGF-18, a novel member of the fibroblast growth factor family, stimulates hepatic and intestinal proliferation.","volume":"18","author":"Hu","year":"1998","journal-title":"Mol Cell Biol"},{"key":"2020071612221685300_R46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.bi.58.070189.003043","article-title":"The heparin-binding (fibroblast) growth factor family of proteins.","volume":"58","author":"Burgess","year":"1989","journal-title":"Annu Rev Biochem"},{"key":"2020071612221685300_R47","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1101\/gad.12.11.1571","article-title":"The roles of FGFs in the early development of vertebrate limbs.","volume":"12","author":"Martin","year":"1998","journal-title":"Genes Dev"},{"key":"2020071612221685300_R48","doi-asserted-by":"crossref","first-page":"11620","DOI":"10.1016\/S0021-9258(19)78170-8","article-title":"Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF\/FGF-1.","volume":"269","author":"Chellaiah","year":"1994","journal-title":"J Biol Chem"},{"key":"2020071612221685300_R49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/08977199509036882","article-title":"Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4.","volume":"12","author":"Hecht","year":"1995","journal-title":"Growth Factors"},{"key":"2020071612221685300_R50","doi-asserted-by":"crossref","first-page":"15292","DOI":"10.1074\/jbc.271.25.15292","article-title":"Receptor specificity of the fibroblast growth factor family.","volume":"271","author":"Ornitz","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071612221685300_R51","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1074\/jbc.271.3.1726","article-title":"Expression and biological activity of mouse fibroblast growth factor-9.","volume":"271","author":"Santos-Ocampo","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071612221685300_R52","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1074\/jbc.272.10.6621","article-title":"Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein.","volume":"272","author":"Kanai","year":"1997","journal-title":"J Biol Chem"},{"key":"2020071612221685300_R53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000133465","article-title":"The fibroblast growth factor receptor 3 gene (FGFR3) is assigned to human chromosome 4.","volume":"62","author":"Keegan","year":"1993","journal-title":"Cytogenet Cell Genet"},{"key":"2020071612221685300_R54","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0888-7543(91)90041-C","article-title":"A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4.","volume":"11","author":"Thompson","year":"1991","journal-title":"Genomics"},{"key":"2020071612221685300_R55","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1073\/pnas.88.4.1095","article-title":"Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3.","volume":"88","author":"Keegan","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612221685300_R56","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s004390050493","article-title":"Human fibroblast growth factor receptor 3 gene (FGFR3): genomic sequence and primer set information for gene analysis.","volume":"100","author":"Wuchner","year":"1997","journal-title":"Hum Genet"},{"key":"2020071612221685300_R57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/geno.1995.9890","article-title":"Genomic organization of the mouse fibroblast growth factor receptor 3 (Fgfr3) gene.","volume":"30","author":"Perez-Castro","year":"1995","journal-title":"Genomics"},{"key":"2020071612221685300_R58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/geno.1997.4616","article-title":"Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene.","volume":"41","author":"Perez-Castro","year":"1997","journal-title":"Genomics"},{"key":"2020071612221685300_R59","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1074\/jbc.273.9.5349","article-title":"Regulation of the fibroblast growth factor receptor 3 promoter and intron I enhancer by Sp1 family transcription factors.","volume":"273","author":"McEwen","year":"1998","journal-title":"J Biol Chem"},{"key":"2020071612221685300_R60","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/bies.950180807","article-title":"Promiscuity of fibroblast growth factor receptors.","volume":"18","author":"Green","year":"1996","journal-title":"Bioessays"},{"key":"2020071612221685300_R61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-5793(93)80882-U","article-title":"A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III.","volume":"330","author":"Avivi","year":"1993","journal-title":"FEBS Lett"},{"key":"2020071612221685300_R62","first-page":"1185","article-title":"Developmental expression of splicing variants of fibroblast growth factor receptor 3 (FGFR3) in mouse.","volume":"40","author":"Wuechner","year":"1996","journal-title":"Int J Dev Biol"},{"key":"2020071612221685300_R63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0925-4773(98)00133-6","article-title":"Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification.","volume":"77","author":"Delezoide","year":"1998","journal-title":"Mech Dev"},{"key":"2020071612221685300_R64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/dbio.1993.1040","article-title":"Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis.","volume":"155","author":"Peters","year":"1993","journal-title":"Dev Biol"},{"key":"2020071612221685300_R65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1096-9861(19970310)379:2<226::AID-CNE5>3.0.CO;2-5","article-title":"Comparative localization of fibroblast growth factor receptor-1, -2, and -3 mRNAs in the rat brain: in situ hybridization analysis.","volume":"379","author":"Belluardo","year":"1997","journal-title":"J Comp Neurol"},{"key":"2020071612221685300_R66","first-page":"645","article-title":"Differential expression of three chick FGF receptor genes, FGFR1, FGFR2 and FGFR3, in limb and feather development","volume":"383B","author":"Noji","year":"1993","journal-title":"Prog Clin Biol Res"},{"key":"2020071612221685300_R67","first-page":"56","article-title":"The type II collagenopathies: a spectrum of chondrodysplasias.","volume":"153","author":"Spranger","year":"1994","journal-title":"Eur J Pediatr"},{"key":"2020071612221685300_R68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/hmg\/4.3.323","article-title":"Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome.","volume":"4","author":"Schell","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2020071612221685300_R69","first-page":"557","author":"Rimoin","year":"1993"},{"key":"2020071612221685300_R70","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/jmg.16.2.140","article-title":"Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine.","volume":"16","author":"Oberklaid","year":"1979","journal-title":"J Med Genet"},{"key":"2020071612221685300_R71","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1399-0004.1989.tb02912.x","article-title":"Birth prevalence rates of skeletal dysplasias.","volume":"35","author":"Stoll","year":"1989","journal-title":"Clin Genet"},{"key":"2020071612221685300_R72","first-page":"24","article-title":"Two probable cases of homozygosity for the achondroplasia gene.","volume":"5","author":"Hall","year":"1969","journal-title":"Birth Defects"},{"key":"2020071612221685300_R73","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ng0394-314","article-title":"The gene for achondroplasia maps to the telomeric region of chromosome 4p.","volume":"6","author":"Velinov","year":"1994","journal-title":"Nat Genet"},{"key":"2020071612221685300_R74","first-page":"368","article-title":"Achondroplasia is defined by recurrent G380R mutations in FGFR3.","volume":"56","author":"Bellus","year":"1995","journal-title":"Am J Hum Genet"},{"key":"2020071612221685300_R75","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01954274","article-title":"A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.","volume":"95","author":"Superti-Furga","year":"1995","journal-title":"Eur J Pediatr"},{"key":"2020071612221685300_R76","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ajmg.1320590325","article-title":"Atypical radiological findings in achondroplasia with uncommon mutation of the fibroblast growth factor receptor-3 (FGFR-3) gene (Gly to Cys transition at codon 375).","volume":"59","author":"Nishimura","year":"1995","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R77","first-page":"151","article-title":"A novel G346E mutation in achondroplasia.","volume":"37","author":"Prinos","year":"1994","journal-title":"Pediatr Res"},{"key":"2020071612221685300_R78","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00210413","article-title":"Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients.","volume":"96","author":"Ikegawa","year":"1995","journal-title":"Hum Genet"},{"key":"2020071612221685300_R79","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1651-2227.1996.tb13963.x","article-title":"Achondroplasia in Sweden caused by the G1138A mutation in FGFR3.","volume":"85","author":"Alderborn","year":"1996","journal-title":"Acta Paediatr"},{"key":"2020071612221685300_R80","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/(SICI)1098-1004(1996)8:2<178::AID-HUMU10>3.0.CO;2-#","article-title":"Fibroblast growth factor receptor 3 (FGFR3) gene G1138A mutation in Chinese patients with achondroplasia.","volume":"8","author":"Wang","year":"1996","journal-title":"Hum Mutat"},{"key":"2020071612221685300_R81","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01900604","article-title":"Predominance of the mutation at 1138 of the cDNA for he fibroblast growth factor receptor 3 in Japanese patients with achondroplasia.","volume":"40","author":"Tonoki","year":"1995","journal-title":"Jpn J Hum Genet"},{"key":"2020071612221685300_R82","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s004390050161","article-title":"Chinese achondroplasia ia also defined by recurrent G380R mutations of the fibroblast growth factor receptor-3 gene.","volume":"98","author":"Niu","year":"1996","journal-title":"Hum Genet"},{"key":"2020071612221685300_R83","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1741-4520.1995.tb00615.x","article-title":"Identification of mutations in the gene encoding the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia.","volume":"35","author":"Kitoh","year":"1995","journal-title":"Congenital Anomalies"},{"key":"2020071612221685300_R84","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/302000","article-title":"Fibroblast growth factor receptor 3 (FGFR3) mutations in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome.","volume":"63","author":"Wilkin","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2020071612221685300_R85","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1148\/133.1.95","article-title":"Hypochondroplasia: clinical and radiological aspects in 39 cases.","volume":"133","author":"Hall","year":"1979","journal-title":"Radiology"},{"key":"2020071612221685300_R86","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1302\/0301-620X.63B4.7298674","article-title":"Achondroplasia and hypochondroplasia: clinical variation and spinal stenosis.","volume":"63","author":"Wynne Davies","year":"1981","journal-title":"J Bone Joint Surg"},{"key":"2020071612221685300_R87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/jmg.10.1.11","article-title":"Observations suggesting allelism of the hypochondroplasia and achondroplasia genes.","volume":"10","author":"McKusick","year":"1973","journal-title":"J Med Genet"},{"key":"2020071612221685300_R88","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ajmg.1320570333","article-title":"Confirmatory linkage of hypochondroplasia to chromosome arm 4p [letter].","volume":"57","author":"Hecht","year":"1995","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R89","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jmg.33.9.749","article-title":"Clinical and genetic heterogeneity of hypochondroplasia.","volume":"33","author":"Rousseau","year":"1996","journal-title":"J Med Genet"},{"key":"2020071612221685300_R90","author":"Bellus","year":"1995"},{"key":"2020071612221685300_R91","author":"Deutz-Terlouw","year":"1998"},{"key":"2020071612221685300_R92","first-page":"83","article-title":"The two recurrent mutations of FGFR3 cause hypochondroplasia in 57% of the Italian patients.","volume":"46","author":"Prinster","year":"1996","journal-title":"Horm Res"},{"key":"2020071612221685300_R93","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/(SICI)1098-1004(1998)11:4<333::AID-HUMU17>3.0.CO;2-J","article-title":"A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia.","volume":"11","author":"Grigelioniene","year":"1998","journal-title":"Hum Mutat"},{"key":"2020071612221685300_R94","author":"Rousseau","year":"1994"},{"key":"2020071612221685300_R95","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jmg.32.6.492-a","article-title":"Possible genetic heterogeneity in hypochondroplasia.","volume":"32","author":"Stoilov","year":"1995","journal-title":"J Med Genet"},{"key":"2020071612221685300_R96","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1096-8628(19980106)75:1<109::AID-AJMG22>3.0.CO;2-P","article-title":"Comparison of clinical-radiological and molecular findings in hypochondroplasia.","volume":"75","author":"Prinster","year":"1998","journal-title":"Am J Med Genet 1998"},{"key":"2020071612221685300_R97","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ajmg.1320550132","article-title":"A common FGFR3 gene mutation is present in achondroplasia but not hypochondroplasia.","volume":"55","author":"Stoilov","year":"1995","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R98","first-page":"2519","article-title":"Le nanisme thanatophore.","volume":"75","author":"Maroteaux","year":"1967","journal-title":"Presse Med"},{"key":"2020071612221685300_R99","author":"Taybi","year":"1995"},{"key":"2020071612221685300_R100","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ajmg.1320330420","article-title":"Growth and development in thanatophoric dysplasia.","volume":"33","author":"MacDonald","year":"1989","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R101","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/(SICI)1096-8628(19970627)70:4<427::AID-AJMG18>3.0.CO;2-J","article-title":"Long-term survival in typical thanatophoric dysplasia type 1.","volume":"70","author":"Baker","year":"1997","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R102","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1006\/bbrc.1996.1495","article-title":"Japanese cases of type 1 thanatophoric dysplasia exclusively carry a C to T transition at nucleotide 742 of the fibroblast growth factor receptor 3 gene.","volume":"227","author":"Pokharel","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612221685300_R103","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C","article-title":"Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia.","volume":"78","author":"Wilcox","year":"1998","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R104","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/(SICI)1096-8628(19990611)84:5<476::AID-AJMG12>3.0.CO;2-X","article-title":"Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations.","volume":"84","author":"Brodie","year":"1999","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R105","author":"Iwata","year":"1997"},{"key":"2020071612221685300_R106","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1096-8628(19990702)85:1<53::AID-AJMG10>3.0.CO;2-F","article-title":"Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.","volume":"85","author":"Bellus","year":"1999","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R107","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/302275","article-title":"A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.","volume":"64","author":"Tavormina","year":"1999","journal-title":"Am J Hum Genet"},{"key":"2020071612221685300_R108","first-page":"362","article-title":"Lys650Met substitution in the tyrosine kinase domain of the FGFR3 gene causes thanatophoric dysplasia type I.","volume":"12","author":"Kitoh","year":"1998","journal-title":"Hum Mutat"},{"key":"2020071612221685300_R109","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/jmg.34.8.632","article-title":"Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis.","volume":"34","author":"Reardon","year":"1997","journal-title":"Med Genet"},{"key":"2020071612221685300_R110","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1086\/302122","article-title":"A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p21.1.","volume":"63","author":"Johnson","year":"1988","journal-title":"Am J Hum Genet"},{"key":"2020071612221685300_R111","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/jmg.34.8.683","article-title":"Phenotypic expression of the fibroblast growth factor receptor 3 (FGFR3) mutation P250R in a large craniosynostosis family.","volume":"34","author":"Golla","year":"1997","journal-title":"J Med Genet"},{"key":"2020071612221685300_R112","first-page":"545","article-title":"Dysostose cranio-faciale hereditaire.","volume":"33","author":"Crouzon","year":"1912","journal-title":"Bull Mem Soc Med Hop Paris"},{"key":"2020071612221685300_R113","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jmg.33.9.744","article-title":"A recurrent mutation, ala391 glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans.","volume":"33","author":"Wilkes","year":"1996","journal-title":"J Med Genet"},{"key":"2020071612221685300_R114","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000121134","article-title":"Jugular foraminal stenosis in Crouzon syndrome.","volume":"25","author":"Martinez-Perez","year":"1996","journal-title":"Pediatr Neurosurg 1996"},{"key":"2020071612221685300_R115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0092-8674(95)90112-4","article-title":"Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?","volume":"83","author":"Schlessinger","year":"1995","journal-title":"Cell"},{"key":"2020071612221685300_R116","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(00)80131-2","article-title":"Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism.","volume":"86","author":"Mohammadi","year":"1996","journal-title":"Cell"},{"key":"2020071612221685300_R117","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/MCB.16.3.977","article-title":"Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction.","volume":"16","author":"Mohammadi","year":"1996","journal-title":"Mol Cell Biol"},{"key":"2020071612221685300_R118","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth.","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"key":"2020071612221685300_R119","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ng0496-390","article-title":"Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.","volume":"12","author":"Colvin","year":"1996","journal-title":"Nat Genet"},{"key":"2020071612221685300_R120","author":"Thompson","year":"1996"},{"key":"2020071612221685300_R121","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0092-8674(94)90520-7","article-title":"The ins and outs of fibroblast growth factors.","volume":"78","author":"Mason","year":"1994","journal-title":"Cell"},{"key":"2020071612221685300_R122","doi-asserted-by":"crossref","first-page":"25049","DOI":"10.1074\/jbc.271.40.25049","article-title":"Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains.","volume":"271","author":"Neilson","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071612221685300_R123","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1128\/MCB.16.8.4081","article-title":"Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II.","volume":"16","author":"Webster","year":"1996","journal-title":"Mol Cell Biol"},{"key":"2020071612221685300_R124","author":"Webster","year":"1996"},{"key":"2020071612221685300_R125","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/j.1460-2075.1996.tb00384.x","article-title":"Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.","volume":"15","author":"Webster","year":"1996","journal-title":"EMBO J"},{"key":"2020071612221685300_R126","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.","volume":"13","author":"Naski","year":"1996","journal-title":"Nat Genet"},{"key":"2020071612221685300_R127","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/386288a0","article-title":"Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism.","volume":"386","author":"Su","year":"1997","journal-title":"Nature"},{"key":"2020071612221685300_R128","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1074\/jbc.273.21.13007","article-title":"Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia.","volume":"273","author":"Legeai-Mallet","year":"1998","journal-title":"J Biol Chem"},{"key":"2020071612221685300_R129","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","article-title":"Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3.","volume":"125","author":"Naski","year":"1998","journal-title":"Development"},{"key":"2020071612221685300_R130","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1073\/pnas.96.8.4455","article-title":"A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.","volume":"96","author":"Wang","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612221685300_R131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/8.1.35","article-title":"A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors.","volume":"8","author":"Li","year":"1999","journal-title":"Hum Mol Genet"},{"key":"2020071612221685300_R132","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1128\/MCB.17.7.4169","article-title":"Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells.","volume":"17","author":"Thompson","year":"1997","journal-title":"Mol Cell Biol"},{"key":"2020071612221685300_R133","doi-asserted-by":"crossref","first-page":"35250","DOI":"10.1074\/jbc.273.52.35250","article-title":"Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation.","volume":"273","author":"Raffioni","year":"1998","journal-title":"J Biol Chem"},{"key":"2020071612221685300_R134","doi-asserted-by":"crossref","first-page":"7894","DOI":"10.1073\/pnas.93.15.7894","article-title":"Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2\/Neu chimeras.","volume":"93","author":"Galvin","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612221685300_R135","first-page":"25","article-title":"Transforming activities of human CSF-1 receptors with different point mutations at codon 301 in their extracellular domain.","volume":"5","author":"Roussel","year":"1990","journal-title":"Oncogene"},{"key":"2020071612221685300_R136","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.7824936","article-title":"Activation of RET as a dominant transforming gene by germ-line mutations of MEN2A and MEN2B.","volume":"267","author":"Santoro","year":"1995","journal-title":"Science"},{"key":"2020071612221685300_R137","doi-asserted-by":"crossref","first-page":"9752","DOI":"10.1016\/S0021-9258(17)36947-8","article-title":"Stabilization of an active dimeric form of the epidermal growth factor by introduction of an inter-receptor disulfide bond.","volume":"269","author":"Sorokin","year":"1994","journal-title":"J Biol Chem"},{"key":"2020071612221685300_R138","doi-asserted-by":"crossref","first-page":"26037","DOI":"10.1074\/jbc.270.44.26037","article-title":"Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome.","volume":"270","author":"Neilson","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071612221685300_R139","first-page":"1310","article-title":"Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome.","volume":"101","author":"Lomri","year":"1998","journal-title":"J Clin Invest"},{"key":"2020071612221685300_R140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1530\/eje.0.1380275","article-title":"Effect of growth hormone therapy in children with achondroplasia: growth pattern, hypothalamic-pituitary function, and genotype.","volume":"138","author":"Tanaka","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2020071612221685300_R141","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1096-8628(19971003)72:1<71::AID-AJMG15>3.0.CO;2-R","article-title":"Growth and growth hormone therapy in children with achondroplasia: a two-year experience.","volume":"72","author":"Stamoyannou","year":"1997","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R142","first-page":"4033","article-title":"Short-term recombinant human growth hormone treatment increases growth rate in achondroplasia.","volume":"81","author":"Shohat","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612221685300_R143","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/(SICI)1096-8628(19960202)61:4<396::AID-AJMG17>3.0.CO;2-N","article-title":"Human growth hormone treatment in prepubertal children with achondroplasia.","volume":"61","author":"Weber","year":"1996","journal-title":"Am J Med Genet"},{"key":"2020071612221685300_R144","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0022-3476(96)70004-5","article-title":"Response to growth hormone in children with chondrodysplasia.","volume":"128","author":"Key Jr","year":"1996","journal-title":"J Pediatr"},{"key":"2020071612221685300_R145","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/nar\/18.11.3227","article-title":"The incidence and distribution of CpG\u220f TpG transitions in the coagulation factor IX gene.","volume":"18","author":"Green","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"2020071612221685300_R146","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/(SICI)1097-0223(199606)16:6<525::AID-PD909>3.0.CO;2-N","article-title":"Errors in the prenatal diagnosis of children with achondroplasia.","volume":"16","author":"Modaff","year":"1996","journal-title":"Prenat Diagn"},{"key":"2020071612221685300_R147","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/(SICI)1097-0223(199608)16:8<764::AID-PD941>3.0.CO;2-M","article-title":"Ultrasound and molecular mid-trimester prenatal diagnosis of de novo achondroplasia.","volume":"16","author":"Mesoraca","year":"1996","journal-title":"Prenat Diagn"},{"key":"2020071612221685300_R148","author":"Jones","year":"1988"},{"key":"2020071612221685300_R149","first-page":"1029","author":"Muenke","year":"1998"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/21\/1\/23\/8859632\/edrv0023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/21\/1\/23\/8859632\/edrv0023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:56:35Z","timestamp":1647910595000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/21\/1\/23\/2423759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2,1]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/edrv.21.1.0387","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2,1]]}}}